A Matter of Life and Death
July 26, 2012 | Story
The Economics of Antibiotic Resistance
You are now viewing 1 - 10 of 60 results
July 26, 2012 | Story
The Economics of Antibiotic Resistance
October 1, 2011 | Journal Article
This study suggests that government incentives are needed to encourage the research and development that goes into producing novel antibiotics, in addition to increasing development of new ones.
November 14, 2011 | Journal Article
Index developed to quantify changes in drug resistance over time.
November 1, 2006 | Journal Article
Since the 1960s, scientists and pharmaceutical representatives have called for the advancement and development of new antimicrobial drugs to combat infectious diseases. In January 2005, Senate Majority Leader Bill Frist (R-TN), M.D., introduced a bi ...
March 1, 2009 | Issue Brief
This policy brief from RWJF grantee Extending the Cure looks at the obstacles around developing a staph vaccine.
August 1, 2010 | Issue Brief
This policy brief from RWJF grantee Extending the Cure examines phages the advantages and disadvantages of phage therapy, other potential applications and the road ahead
February 26, 2009 | Commentary/Story
Some 5 percent of patients admitted to a U.S. hospital will contract an infection during their stay. Such infections cause a staggering 99,000 deaths per year, and a growing proportion no longer respond to a wide range of antibiotics. The RWJF-funded Extending the Cure project has published three op-ed articles recently on this critical topic.
July 30, 2012 | Pioneering Ideas Blog Post
Brian Quinn weighs in on Extending the Cure Project Director Ramanan Laxminarayan’s suggestion that we view antibiotics effectiveness as a natural resource.
March 20, 2009 | News Release/Video
"Positive deviance" efforts turn the tide on antibiotic-resistant infections.
August 21, 2012 | Pioneering Ideas Blog Post
Extending the Cure Director Ramanan Laxminarayan examines the dangers of antibiotic overuse.